diabetestalk.net

Diabetes Stem Cell Treatment Uk

Stem Cell Transplant Trial 'has Miraculous Effect' On Multiple Sclerosis Sufferers

Stem Cell Transplant Trial 'has Miraculous Effect' On Multiple Sclerosis Sufferers

Stem cell transplant trial 'has miraculous effect' on multiple sclerosis sufferers 'It does feel like a miracle. I almost have to pinch myself and think "Is this real l? Is it really gone, is it ever going to come back?"' Two years after having treatment, MS sufferer Louise Willetts has seen her symptoms disappear and has started a family Stem cell transplant trial 'has miraculous effect' on multiple sclerosis sufferers Doctors are hailing a new stem cell treatment for the degenerative disease multiple sclerosis, after trials showed it to reboot patients immune systems, halting the disease. Patients said the results were a miracleand had seen them return to normal life after the disease left them in a wheelchair or unable to read. Around 100,000 people in the UK have multiple sclerosis, a condition where the immune system attacks the nerves of the brain and spinal cord causing problems with vision, movement, and balance. Early results from a clinical trial run from four international centres show that wiping out the patients immune systems with chemotherapy, and restoring themwith the new stem cell treatment,appears to halt the disease and improve symptoms. Cannabis-based drug to be offered to NHS Wales patients with multiple We are thrilled with the results they are a game-changer for patients with drug-resistant and disabling multiple sclerosis, Professor John Snowden, director of blood and bone marrow transplantation at Sheffields Royal Hallamshire Hospital, which led the UK part of the trial, told the BBC. Independent experts also welcomed the trial, and called on the NHS to ensure everyone who could benefit from stem cell transplantation canaccess it. The treatment, called haematopoietic stem cell transplantation (HSCT), was trialled in a group of 100 patients wit Continue reading >>

Stem Cell Breakthrough Offers Diabetes Hope

Stem Cell Breakthrough Offers Diabetes Hope

Stem cell breakthrough offers diabetes hope Stem cell breakthrough offers diabetes hope Scientists have discovered a new technique for turning embryonic stem cells into insulin-producing pancreatic tissue in what could prove a significant breakthrough in the quest to find new treatments for diabetes. The University of Manchester team, working with colleagues at the University of Sheffield, were able to genetically manipulate the stem cells so that they produced an important protein known as a transcription factor. Stem cells have the ability to become any type of cell, so scientists believe they may hold the key to treating a number of diseases including Alzheimers, Parkinsons and diabetes. However, a major stumbling block to developing new treatments has been the difficulty scientists have faced ensuring the stem cells turn into the type of cell required for any particular condition in the case of diabetes, pancreatic cells. Unprompted, the majority of stem cells turn into simple nerve cells called neurons, explained Dr Karen Cosgrove, who led the team in Manchesters Faculty of Life Sciences. Less than one per cent of embryonic stem cells would normally become insulin-producing pancreatic cells, so the challenge has been to find a way of producing much greater quantities of these cells. The pancreas contains different types of specialised cells exocrine cells, which produce enzymes to aid digestion, and endocrine cells, including beta cells, which produce the hormone insulin to regulate the blood glucose levels. Diabetes results when there is not enough insulin to meet the bodys demands. There are two forms of the disease: type-1 diabetes is due to not enough insulin being produced by the pancreas, while type-2 or adult-onset diabetes occurs when the body fails to res Continue reading >>

Diabetes, Your Family, And How Stem Cells Could Help The Problem In The Middle East

Diabetes, Your Family, And How Stem Cells Could Help The Problem In The Middle East

Diabetes, your family, and how stem cells could help the problem in the Middle East Home Diabetes, your family, and how stem cells could help the problem in the Middle East Diabetes is the 21st centurys leading health care challenge. If its not an issue for you, then it will certainly be an issue for your children. A staggering 31% of all deaths in the UAE are caused by diabetes and correlated cardiovascular disease. And by 2035, the number of people with type 2 diabetes in the UAE is projected to increase by 96.2%. As ongoing research and successful clinical trials continue to reveal, stem cell therapy could hold the key to solving this global health problem in both type 1 and type 2 diabetes. By storing your childs stem cells, you have acquired an insurance policy for the future, when the research were going to discuss today may become commonplace across the world in treating sufferers of diabetes. So lets look at what this means for you and your family. Out of the estimated total of 445 million people living with diabetes worldwide, the majority suffer from type 2 diabetes, the form of the disease where the pancreas produces insufficient insulin or the body becomes resistant to its effects. As the body becomes insulin-resistant, the resulting high glucose levels can cause complications, which can severely damage the eyes, kidneys and nervous system. Type 2 diabetes is also associated with an increased risk of dementia, can double the risk of heart attack and stroke, and can lead to digestive problems. As the body becomes insulin-resistant, the resulting high glucose levels can cause complications, which can severely damage the eyes, kidneys and nervous system. The rapid increase in the prevalence of type 2 diabetes, which develops slowly, often going unnoticed for y Continue reading >>

Bone Marrow Stem Cells And Diabetes

Bone Marrow Stem Cells And Diabetes

Home > Uses for Stem Cells > Bone Marrow Stem Cells and Diabetes By: Ian Murnaghan BSc (hons), MSc - Updated: 11 Mar 2018| The prevalence of diabetes has been growing and the goal of finding a cure or more effective treatment than current options has become increasingly important. Ongoing research since the turn of the century has shown that when diabetic mice are injected with bone marrow stem cells the stem cells were able to restore function to damaged tissues. The findings are exciting for both researchers and those who suffer from diabetes. It is hoped that continuing trials and research will eventually bring effective treatments to the public. Diabetes refers to a condition whereby the body cant produce the hormone insulin or the bodys cells are resistant to its effects. For type 1 diabetics, their pancreas doesnt produce the insulin required to keep blood sugar within its preferred, finely tuned range. In type 2 diabetes, insulin production generally occurs, albeit abnormally but the bodys cells cant properly use the hormone to regulate blood sugar. Diabetics may be insulin dependent, where they require daily doses of insulin to balance out their food consumption, or they may be able to manage their condition with diet and exercise. The complications of diabetes are, however, enormous. Diabetes has a high morbidity, with complications ranging from circulatory problems, nerve problems and heart disease to blindness. In addition, the daily challenge of monitoring lifestyle and taking insulin when required can be mentally and physically exhausting for many diabetics. Studies in both Canada and the United States found that when stem cells were injected into the bloodstream of diabetic mice, the stem cells found their way to the damaged pancreas, where they were able Continue reading >>

Diabetes | Mrc Centre For Regenerative Medicine

Diabetes | Mrc Centre For Regenerative Medicine

Diabetes occurs when the pancreas fails to produce enough insulin or the insulin that is produced does not work properly. Insulin is a hormone produced by the beta cells in the pancreas that allows glucose to move from the bloodstream into cells to provide them with energy. Not having enough insulin results in abnormal blood glucose levels and cells in the body not functioning properly. In the UK more than 3.2M people are diagnosed with diabetes, and numbers in Scotland have doubled over the past 10 years. The healthcare costs of treating and caring for diabetes patients in Scotland alone have risen to more than 1b. Type 2 diabetes is the most common form and occurs when the pancreas doesnt make enough insulin or the insulin produced cannot function properly. In many cases Type 2 diabetes can be managed by controlling the diet, exercising and self-monitoring blood glucose. However, if blood sugar levels cannot be controlled, insulin production stops resulting in a similar disease course as Type 1 (described below). Type 1 diabetes is an autoimmune condition where the bodys own defence system mistakenly attacks and destroys the beta cells in the pancreas that produce insulin. Diabetic ketoacidosis (DKA) is a life-threatening condition where the body starts to break down other body tissue as an alternative energy source to glucose. This produces toxic by-products called ketones. DKA accounts for around half of all diabetes-related hospital admissions in people with type 1 diabetes. What causes the immune system to attack the beta cells in Type 1 diabetes is not entirely known and there is currently no cure. Most patients with type 1 diabetes can stabilize their blood glucose levels by regularly administering insulin (either by injections, or an insulin pump) but there ar Continue reading >>

Cell Therapy For Type 1 Diabetes

Cell Therapy For Type 1 Diabetes

The aim of this study is to provide an alternative supply of islets of Langerhans (islets) for transplantation in the treatment of type 1 diabetes. Islets are clusters of cells located throughout the pancreas that produce and secrete insulin. In type 1 diabetes islets are completely destroyed via an autoimmune process, and people with type 1 diabetes are dependent on multiple daily insulin injections. Recently, islet transplantation has been introduced as a viable alternative therapeutic option for a large number of people with type 1 diabetes. However, a major barrier to the widespread application of islet transplantation is the scarcity of cadaveric donor tissue. A healthy individual has about 1 million islets representing around 2% of the pancreas. The remaining part of the pancreas, the exocrine tissue, is normally discarded after the islets are isolated. We propose to reprogramme this redundant exocrine tissue into functional islets with the potential to increase the number of transplants from around 35 per year to several hundred. The cells will be reprogrammed by genetically modifying the cells to express molecules that have the ability to convert the exocrine tissue to islets. The human exocrine-enriched tissue will be provided by the Scottish islet Transplantation Centre, which is based in the Scottish National Blood Transfusion Centre in Edinburgh. The reprogramming protocol will be performed at the University of Aberdeen. To establish the reproducibility and to optimize further the protocol additional studies will be performed at the Free University in Brussels. The reprogramming protocol takes around 10 days to perform, while the study itself will last for five years with the expectation that clinical trials will be underway by 2019.\n\nIt is now well recog Continue reading >>

What Is Stem Cell Therapy, And How Can It Help Diabetes Sufferers?

What Is Stem Cell Therapy, And How Can It Help Diabetes Sufferers?

What is stem cell therapy, and how can it help diabetes sufferers? What is stem cell therapy, and how can it help diabetes sufferers? Care & Medication Diabetes is a chronic disease which is developed when the pancreas does not produce enough insulin (Type 1 diabetes) or when the body cannot effectively use the insulin it produces (Type 2 diabetes). According to a recent World Health Organisation report, diabetes mellitus is one of the top ten leading causes of death worldwide. In the world every 10 seconds, one patient with diabetes mellitus dies. Average life expectancy for children with diabetes mellitus doesn't exceed 28 years from the time of their diagnosis. It is important to note that if diabetes mellitus isnt treated properly, it can cause a huge amount of damage: to the eyes (leading to blindness), kidneys (leading to renal failure), nerves (leading to impotence, foot disorders such as diabetic foot ulcers, painful muscle wasting and weakness, as well as altered pain sensation), heart and blood vessels (development of cardiovascular diseases such as coronary artery disease, myocardial infarction, stroke and insufficiency in blood flow to legs-peripheral vascular disease). The existing standard treatment for patients with type 1 diabetes mellitus consists of lifelong exogenous insulin administration, which is often associated with debilitating hypoglycemic episodes. This can be inconvenient for the patient and does not completely prevent the development of diabetic complications. In its early stages, Type 2 diabetes mellitus can be treated by oral hypoglycemic medication. However, eventually, patients with type 2 diabetes mellitus become insulin dependent. Insulin injections are therefore also used in the therapy of type 2 diabetes mellitus. There are differen Continue reading >>

Diabetes And Stem Cell Research

Diabetes And Stem Cell Research

Stem cell research is in progress for the treatment of diabetes Understanding the root causes of diabetes has eluded researchers for many years now. The way in which the immune system causes the destruction of precious beta islet cells within the pancreas of type 1 diabetics is generally understood to be the key. The ultimate goal, which has so far proved elusive, is a cure for diabetes , which could potentially be available for both types of diabetes through stem cell research. Stem cells are a form of cell that is yet to develop a specific set of traits. However, what stem cells have in abundance is the potential to develop into a number of different forms. Stem cell research covers the scientific study of these stem cells. Stem cell research allows researchers to grow specific varieties of human cells in the lab and research how they behave and interact under different conditions. Stem cells open up a wide spectrum of diabetes research possibilities. In one example of diabetes stem cell research, researchers took cells from human intestine cells and disabled a gene which enabled the cells to produce insulin. Stem cells for the treatment of diabetes are able to come from a variety of sources. Stem cells in the research of type 1 diabetes Within recent years, stem cell research has become a very important part of the scientific understanding of type 1 diabetes. Research has demonstrated that stem cells can be grown in the lab. In 2004, the University of Pittsburgh grew insulin producing beta cells by introducing two genes cdk and cyclin d via a virus. The researchers were able to deactivate the virus and also prevent stem cells from growing further. The research could lead to a better availability of beta cells for future research purposes. Progenitor cells, related t Continue reading >>

Cambridge Discovery Paves The Way For New Diabetes Treatment Options

Cambridge Discovery Paves The Way For New Diabetes Treatment Options

3D clusters of pancreatic cells, called organoids, grown in the Wellcome Trust MRC Cambridge Stem Cell Institute, are used to study new ways to improve pancreatic function in diabetes. Cambridge stem cell scientists have revealed a new mechanism controlling the formation of insulin-producing pancreatic beta cells. These beta cells are the same cells that are damaged and lost in people living with diabetes. With this new understanding, researchers now have the opportunity to improve the production of functional beta cells in the lab which could be used to replace the insulin-producing cells lost in diabetes, offering better treatment options for this disease in future. The research team, led by Professor Anna Philpott at the Wellcome TrustMedical Research Council Cambridge Stem Cell Institute, used developing frogs eggs and mouse pancreas tissue, as well as 3D organoids (lab-grown clusters of cells mimicking the pancreas), to understand how these important cells grow and function during development. The team found that a critical protein, known as neurogenin3, can be modified by the addition of a phosphate chemical tag. This modification controls the ability of neurogenin3 to regulate the production of new pancreatic hormone-producing cells. This new finding appears in the journal Developmental Cell , and has the potential to contribute significantly towards improving future outcomes in diabetes. Over 1 in 20 people in the UK are living with diabetes, and 24,000 people with diabetes die early each year. The condition also represents a huge economic burden, with diabetes calculated to cost the NHS 10 billion per year (The Cost of Diabetes Report Diabetes UK). There are a number of methods which we can explore to restore beta cell function in people living with diabetes, Continue reading >>

Diabetes Mellitus: A Potential Target For Stem Cell Therapy.

Diabetes Mellitus: A Potential Target For Stem Cell Therapy.

Diabetes mellitus: a potential target for stem cell therapy. Division of Immunology and Endocrinology, National Institute for Biological Standardisation and Control, Potters Bar, Hertfordshire, EN6 3QG, UK. [email protected] Type 1 diabetes mellitus has received much attention recently as a potential target for the emerging science of stem cell medicine. In this autoimmune disease, the insulin-secreting beta-cells of the pancreas are selectively and irreversibly destroyed by autoimmune assault. Advances in islet transplantation procedures now mean that patients with the disease can be cured by transplantation of primary human islets of Langerhans. A major drawback in this therapy is the availability of donor islets, and the search for substitute transplant tissues has intensified in the last few years. This review will describe the essential requirements of a material designed as a replacement beta-cell and will look at the potential sources of such replacements. These include embryonic stem (ES) cells and multipotent adult stem/progenitor cells from a range of tissues including the pancreas, intestine, liver, bone marrow and brain. These stem cell populations will be evaluated and the different experimental approaches that have been employed to derive functional insulin-expressing cells will be discussed. The review will also look at the capability of human ES (hES) cells generated by somatic cell nuclear transfer and some adult stem cell populations such as bone marrow-derived stem cells, to offer autologous transplant material that would remove the need for immunosuppression. In patients with Type 1 diabetes, auto-reactive T-cells are programmed to recognise the insulin-producing beta-cells. As a result, for therapeutic replacement tissues, it may be more sensible Continue reading >>

Stem Cell Therapy And Diabetes

Stem Cell Therapy And Diabetes

Almost 3.7 million people have been diagnosed with diabetes in the UK 12.3 million people are at increased risk of Type 2 diabetes in the UK 4.6 million people are living with diabetes in the UK 1 in 4 people with diabetes in the UK are unaware of their condition Treating Diabetes and its complications currently costs the NHS almost 10 billion each year Source: Diabetes UK & Public Health England 4.6 million people in the UK are living with diabetes, a figure that has doubled in the last 20 years alone, according to Diabetes UK* and which is forecast to increase further over the coming years. Stem cell therapy has been described as the next frontier for diabetes treatment for both Type 1 and Type 2 diabetes. Diabetes is the long-life health condition that occurs when the bodys ability to produce or respond to the hormone insulin is impaired, resulting in the amount of glucose (sugar) in the body being too high, because the body cant use it properly. In Type 1 diabetes, the bodys immune system destroys the insulin-producing beta cells (b-cells) of the pancreas. In Type 2 diabetes, the more common form, this is characterised by insulin resistance, and by subsequent progressive decline in b-cell function to the point that the cells can no longer produce enough additional insulin to overcome the insulin resistance. Research into Stem Cell Treatment for Diabetes The good news is that researchers are actively exploring cell replacement therapy as a potential strategy to treat Type 1 diabetes, and research has already demonstrated that Mesenchymal Stem Cells ( cells from teeth ) can differentiate into insulin secreting cells. In fact, dental pulp stem cells are considered to be the most optimal source for MSCs. They are noncontroversial, easily accessible, and collection pres Continue reading >>

Diabetes Type 1 Uk Patient Treatment Story

Diabetes Type 1 Uk Patient Treatment Story

NEW modern technology - activating autologous own stem cells and replacing the damaged cells Patients satisfied with the stem cells therapy I hope you are all well. Things are great here - my sleep is a lot better 6 hour stretches now and able to get back to sleep when disturbed, all without drugs for first time in 27 years. My legs are getting stronger thanks to the wonderful Physio and exercises. I can see a day in the near future when I wont need a stick. My digestion is a lot better so no unconfortable tummy aches. I am a lot calmer and thinking clearer, the stress of illness has gone from my face which a lot of people have noticed, saying I look so well. I, will keep reporting, I am so happy (I thought I would never be well again but I am. Thanks to all of you). Have a great Christmas all at Belgrade. Love Would you please pass on the following messages to my dear friends at the Moscow clinic. Please say hello to Katya and Liluba, who looked after me with such love and care, I will never forget their kindness. Hello to Tanya (no pain, normal). A special thanks to Alexandria with much love and best wishes for her future. I regret I didn't have the chance to say goodbye and thank you to Vitaliy Nikitin for all he did for me. Could you thank him from the bottom of my heart for his kindness and caring. There were just too many others to list individually here, but I would like to send a big thank you to all the staff who showed such love and kindness to myself and Denyse during our stay. Our stay at the clinic felt like being part of a large and loving family and I will cherish that memory forever. Uro is staying healthy and happy and there are some changes in his condition. He is using a real toilet now; he do more things by himself - like taking clothes and shoes on Continue reading >>

Turning Stem Cells Into Beta Cells

Turning Stem Cells Into Beta Cells

Evaluating a decellularised pancreas matrix for islet bioengineering and diabetes therapy In diabetes, insulin-producing beta cells are destroyed or stop working properly. New beta cells can be made in a lab, and Dr Hill wants to find ways to improve this process. This could help scientists to improve the effectiveness of islet cell transplants to treat Type 1 and 2 diabetes. In Type 1 diabetes, insulin-producing beta cells in the pancreas are destroyed by the immune system. In Type 2 diabetes, the same cells stop working properly. Scientists are testing ways to transplant beta cells into people with diabetes so they are able to make the insulin they need to control blood glucose levels. This is currently possible for some people with Type 1 diabetes, where they receive new cells from a donor pancreas. In order to improve this, we need more beta cells to transplant. Most cells in the body have a particular purpose. Stem cells are different and can develop into many different types of cells, including beta cells (a process known as stem cell differentiation). But so far, new beta cells made with this method havent worked very well. Dr Hill wants to test a new method, to improve the number of beta cells produced and how well they work. Dr Hill will look at ways to produce fully working beta cells from stem cells. In the body, beta cells are surrounded by a supportive structure thats known as an extracellular matrix. Dr Hill and her team will use a different type of matrix (taken from a mouse pancreas), to see if this can support the stem cells to turn into functioning beta cells. They will then transplant the new beta cells into mice, to see if they could potentially be used to treat Type 1 diabetes. Potential benefit to people with diabetes If we can establish the best Continue reading >>

Nhs Starts 'stem Cell Factory' For Diabetes

Nhs Starts 'stem Cell Factory' For Diabetes

NHS starts 'stem cell factory' for diabetes These are external links and will open in a new window The NHS is setting up a stem cell factory in Liverpool to treat people with diabetes. NHS Blood and Transplant wants to make and give the experimental therapy to patients at high risk of developing diabetes-related kidney problems. It is hoped the injections will slow down or stop tissue damage, removing the need for dialysis or transplants. Diabetes is the most common cause of end stage kidney disease, which kills around 40,000 people a year in the UK. The 48 patients taking part in the study will be treated at University Hospitals Birmingham NHS Foundation Trust and Belfast Health and Social Care Trust or at another trial site in Italy. The injection of cells they will receive are called stromal cells and they are grown from donated human bone marrow. These immature cells can grow and change into a variety of tissue - bone, cartilage and fat. But it is their ability to release proteins that reduce inflammation in the kidney which interests the researchers. Image copyright SCIEPRO/SCIENCE PHOTO LIBRARY In animal studies, stromal cell injections have provided measurable improvements in kidney function and it is hoped they will do the same in people. Only some of the patients in the study will get the real jab (at different doses). The others will get a dummy injection. This will let the investigators check whether the treatment really works and if it has any side effects. Project leader Prof Timothy O'Brien, from the National University of Ireland, Galway, said: "Diabetic kidney disease is very common so any therapy that could slow the progression of this disease would have a significant impact." About three in four people with diabetes will develop kidney disease. It is Continue reading >>

Stem Cells 'cure Diabetes'

Stem Cells 'cure Diabetes'

What does the NHS Knowledge Service make of this study? "Stem cell transplants 'have freed patients with type 1 diabetes of daily insulin injections'" The Daily Telegraph has said. The news comes after research which allowed volunteers to go, on average, for two and a half years without using the multiple daily injections normally needed to manage their condition. The small study involved 23 patients with newly-diagnosed type 1 diabetes, a condition in which the immune system can rapidly destroy the insulin-producing cells in the pancreas. These stem cell transplants apparently work by resetting the immune system so that the body stops attackingthe pancreas. The researchers themselves say that this treatment can only be used when the condition is caught early enough (within six weeks of diagnosis), before the pancreas has been irreversibly damaged andbefore anycomplications from very high blood sugar have developed. The study provides another avenue for research, but this treatment is still at a early stage of development and does come with some side effects and risks. Dr Iain Frame, research director of Diabetes UK, has emphasised that "this is not a cure for type 1 diabetes. This research was conducted by Dr Carlos EB Couri and colleagues from the University of Sao Paulo, Brazil along with Dr Richard K Burt from the Division of Immunotherapy, Northwestern University Feinberg School of Medicine in Chicago. The study was supported by a range of public and private organisations including the Brazilian Ministry of Health, Genzyme Corporation and Johnson & Johnson. The study was published in the peer-reviewed Journal of the American Medical Association. This was a prospective case series of 23 individuals who had received stem cell treatment to treat new onset cases of ty Continue reading >>

More in diabetes